Press Releases
Bio2 Technologies, Inc. Enrolls First Vitrium Patient in Cervical Spine Fusion Trial. Click Here to view.
Bio2 Technologies, Inc. Receives FDA IDE Approval to Begin Clinical Study of Resorbable Cervical Interbody Device for Spinal Fusion. Click Here to view.
Bio2 Technologies, Inc. Secures Series C Financing Led by DSM Venturing. Click Here to view.
Bio2 Technologies, Inc. Announces Results from Ovine Spinal Fusion Study at the 2017 Orthopedic Research Society Meeting. Click Here to view.
Bio2 Technologies, Inc. Announces Receipt of FDA 510(k) Clearance for CLM Bioactive Scaffold. Click Here to view.